晚期黑色素瘤患者的肺部浸润
一例60岁转移性黑色素瘤男性患者,接受伊匹木单抗联合纳武利尤单抗治疗四周期后出现干咳和轻度劳力性呼吸困难,胸部影像显示双侧肺门增大、纵隔淋巴结增大及弥漫性磨玻璃结节,提示肺部浸润。本文通过病例展示和文献回顾,讨论诊断与管理挑战,并总结作者建议的管理方法。
要点
- 免疫检查点抑制剂治疗后出现肺部浸润需鉴别免疫相关肺炎、感染及肿瘤进展。
- 该患者有黑色素瘤病史及吸烟史,影像示纵隔淋巴结增大和弥漫性磨玻璃结节。
- 作者通过病例讨论和文献回顾,提出对这类患者的诊断与管理建议。
核心结论
- 本文通过一例晚期黑色素瘤患者免疫治疗后出现肺部浸润的病例,讨论了诊断与管理挑战,并总结了作者建议的管理方法。
研究设计与样本
- 肿瘤学大查房系列文章,包含病例展示、诊断与管理挑战描述、相关文献回顾及作者建议的管理方法总结。
主要发现
- 患者为60岁既往吸烟男性,5年前诊断左胸壁黑色素瘤(T3a N0 M0,深度2.7 mm,无溃疡),手术后未接受其他治疗。
- 4年后切除左小腿隆起色素性皮损,病理为黑色素瘤且切缘阳性,再切除后2个月出现左髋部软组织结节,PET-CT示皮下组织、肌肉骨骼及骨髓多发高代谢病灶,符合晚期黑色素瘤。
- 开始伊匹木单抗联合纳武利尤单抗全身治疗,四周期后出现干咳和轻度劳力性呼吸困难(改良医学研究委员会呼吸困难量表评分2分),胸部X线示双侧肺门增大、右侧气管旁条纹增厚及双肺散在斑片状间质纹理增多。
- PET和胸部CT示纵隔淋巴结增大伴[18F]氟脱氧葡萄糖摄取增高,双肺散在弥漫性1-2 mm结节伴磨玻璃影。
- 患者吸烟史为每日一包共35年,6年前戒烟,无肺炎、儿童哮喘或结核病史,母亲有哮喘史。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 60-year-old former smoker with metastatic melanoma presented with the chief complaint of pulmonary infiltrates. Five years ago, he was diagnosed with a left chest wall melanoma. He underwent surgery but received no additional therapy for an American Joint Committee on Cancer stage T3a N0 M0 tumor that was 2.7 mm in depth with no ulceration of the epidermal surface. Resection margins were free of tumor. Four years later, he underwent excision of a raised pigmented skin lesion on his left calf that proved to be melanoma with positive margins. He underwent re-excision of melanoma but 2 months later developed a new left hip soft tissue nodule. Positron emission tomography (PET) -computed tomography showed multiple hypermetabolic lesions involving subcutaneous tissue, muscle osseous structures, and bone marrow, consistent with advanced melanoma. He began systemic therapy with ipilimumab and nivolumab. After four cycles of immunotherapy, he developed a nonproductive cough and mild dyspnea on exertion (Modified Medical Research Council dyspnea scale score of 2 [ie, he had to stop for breath when walking at his own pace on level ground]). A chest x-ray showed bilateral hilar enlargement, thickening of the right paratracheal stripe, and scattered patchy increased interstitial markings bilaterally. PET and chest computed tomography images showed enlarged mediastinal adenopathy with increased [18F]fluorodeoxyglucose uptake on PET and scattered diffuse 1- to 2-mm pulmonary nodules with ground-glass opacities ( Fig 1 ). The patient was referred for pulmonary input. The patient had smoked one pack of cigarettes per day for 35 years; he quit 6 years ago. He had no history of pneumonia, childhood asthma, or tuberculosis. His mother had asthma, but there was no other family history of asthma or other lung disease.
引用
- Powell CA. Pulmonary Infiltrates in a Patient With Advanced Melanoma. J Clin Oncol. 2016. PMID: 28029320. doi:10.1200/JCO.2016.69.9793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。